Bronchial thermoplasty attenuates bronchodilator responsiveness

Area of Science:

• Pulmonary Medicine
• Respiratory Physiology
• Interventional Pulmonology

Background:

• Bronchial thermoplasty (BT) is an established treatment for severe asthma, improving symptoms and reducing exacerbations.
• The primary proposed mechanism for BT's efficacy is the reduction of airway smooth muscle (ASM).
• A reduction in ASM mass could potentially alter airway responsiveness to bronchodilators.

Purpose of the Study:

• To investigate the impact of bronchial thermoplasty on bronchodilator responsiveness in patients with severe asthma.
• To determine if the reduction in airway smooth muscle mass following thermoplasty affects the efficacy of bronchodilator medication.

Main Methods:

• Eight patients with uncontrolled severe asthma underwent spirometry and oscillometry.
• Lung function and respiratory mechanics were assessed before and after salbutamol administration.
• Measurements were taken before and at least one year after bronchial thermoplasty.

Main Results:

• Bronchial thermoplasty did not improve baseline lung function or respiratory mechanics but improved asthma symptoms.
• Spirometric measures of bronchodilator response (FEV1, FVC, FEV1/FVC) remained unaffected by thermoplasty.
• Oscillometric parameters (reactance at 5 Hz and reactance area) showed an attenuated response to salbutamol post-thermoplasty.

Conclusions:

• Bronchial thermoplasty attenuates the bronchodilator response, particularly evident in oscillometric measurements.
• This attenuated response serves as physiological evidence supporting the mechanism of airway smooth muscle reduction by thermoplasty.
• The findings suggest a complex interplay between airway remodeling and bronchodilator efficacy after bronchial thermoplasty.